dostęp otwarty
Tom 14, Nr 4 (2020)
Artykuł redakcyjny
Opublikowany online: 2020-09-01
Pobierz cytowanie
COVID-19 — czego nauczyło nas pierwsze półrocze pandemii?
Forum Medycyny Rodzinnej 2020;14(4):143-150.
dostęp otwarty
Tom 14, Nr 4 (2020)
Artykuł redakcyjny
Opublikowany online: 2020-09-01
Streszczenie
W niniejszym artykule podsumano podstawowe doświadczenia i zakres wiedzy zebranych
w pierwszym półroczu pandemii SARS- CoV-2 — w zakresie epidemiologii, profilaktyki,
diagnostyki, obrazu klinicznego i zagrożeń związanych z COVID-19, a także zebrano podstawowe
wątpliwości i pytania na przyszłość, wymagające odpowiedzi przed kolejnymi falami
zachorowań i odległymi następstwami tej pandemii.
Streszczenie
W niniejszym artykule podsumano podstawowe doświadczenia i zakres wiedzy zebranych
w pierwszym półroczu pandemii SARS- CoV-2 — w zakresie epidemiologii, profilaktyki,
diagnostyki, obrazu klinicznego i zagrożeń związanych z COVID-19, a także zebrano podstawowe
wątpliwości i pytania na przyszłość, wymagające odpowiedzi przed kolejnymi falami
zachorowań i odległymi następstwami tej pandemii.
Pobierz cytowanie
Słowa kluczowe
SARS-CoV-2, COVID-19, pandemia, epidemiologa, profilaktyka, obraz kliniczny, leczenie, przeciwciała
Informacje o artykuleTytuł
COVID-19 — czego nauczyło nas pierwsze półrocze pandemii?
Czasopismo
Numer
Typ artykułu
Artykuł redakcyjny
Strony
143-150
Opublikowany online
2020-09-01
Wyświetlenia strony
841
Wyświetlenia/pobrania artykułu
70
Rekord bibliograficzny
Forum Medycyny Rodzinnej 2020;14(4):143-150.
Słowa kluczowe
SARS-CoV-2
COVID-19
pandemia
epidemiologa
profilaktyka
obraz kliniczny
leczenie
przeciwciała
Autorzy
Tomasz Smiatacz
Referencje (43)- Beszczyński W. Jak długo żyli ludzie w XIX wieku. http://www.ptg.gda.pl/index.php/publisher/articleview/action/view/frmArticleID/23/ (28.07.2020).
- Kołpak P. Na co umierali nasi przodkowie? http://zywiecinfo.pl/historia/na-co-umierali-nasi-przodkowie-czesc-i (28.07.2020).
- Zunyou W: Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention, JAMA. 2020;323(13):1239-1242. doi:10.1001/jama.2020.2648.
- Steensels D, Oris E, Coninx L, et al. Hospital-Wide SARS-CoV-2 Antibody Screening in 3056 Staff in a Tertiary Center in Belgium. JAMA. 2020; 324(2): 195.
- Brown NE, Bryant-Genevier J, Bandy U, et al. Antibody Responses after Classroom Exposure to Teacher with Coronavirus Disease, March 2020. Emerg Infect Dis. 2020 [Epub ahead of print]; 26(9).
- Hendrix MJ, Walde C, Findley K, et al. Absence of Apparent Transmission of SARS-CoV-2 from Two Stylists After Exposure at a Hair Salon with a Universal Face Covering Policy - Springfield, Missouri, May 2020. MMWR Morb Mortal Wkly Rep. 2020; 69(28): 930–932.
- Hamner L, Dubbel P, Capron I, et al. High SARS-CoV-2 Attack Rate Following Exposure at a Choir Practice — Skagit County, Washington, March 2020. MMWR. Morbidity and Mortality Weekly Report. 2020; 69(19): 606–610.
- Payne DC, Smith-Jeffcoat SE, Nowak G, et al. CDC COVID-19 Surge Laboratory Group. SARS-CoV-2 Infections and Serologic Responses from a Sample of U.S. Navy Service Members - USS Theodore Roosevelt, April 2020. MMWR Morb Mortal Wkly Rep. 2020; 69(23): 714–721.
- Bahl P, Bhattacharjee S, de Silva C, et al. Face coverings and mask to minimise droplet dispersion and aerosolisation: a video case study. Thorax. 2020 [Epub ahead of print].
- Wang X, Ferro EG, Zhou G, et al. Association Between Universal Masking in a Health Care System and SARS-CoV-2 Positivity Among Health Care Workers. JAMA. 2020 [Epub ahead of print].
- Ing A, Cocks C, Green J. COVID-19: in the footsteps of Ernest Shackleton. Thorax. 2020; 75(8): 693–694.
- https://www.trackcorona.live/.
- https://coronavirus.jhu.edu/data.
- Streeck H, Schulte B, Kuemmerer B, et al. Infection fatality rate of SARS-CoV-2 infection in a German community with a super-spreading event. .
- Stringhini S, Wisniak A, Piumatti G, et al. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study. The Lancet. 2020.
- Pollán M, Pérez-Gómez B, Pastor-Barriuso R, et al. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study. The Lancet. 2020.
- Tenforde M, Kim S, Lindsell C, et al. Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network — United States, March–June 2020. MMWR. Morbidity and Mortality Weekly Report. 2020; 69(30).
- Ackermann M, Verleden SE, Kuehnel M, et al. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. N Engl J Med. 2020; 383(2): 120–128.
- Merkler A, Parikh N, Mir S, et al. Risk of Ischemic Stroke in Patients With Coronavirus Disease 2019 (COVID-19) vs Patients With Influenza. JAMA Neurology. 2020.
- Solomon MD, McNulty EJ, Rana JS, et al. The Covid-19 Pandemic and the Incidence of Acute Myocardial Infarction. N Engl J Med. 2020 [Epub ahead of print].
- Lange SJ, Ritchey MD, Goodman AB, et al. Potential Indirect Effects of the COVID-19 Pandemic on Use of Emergency Departments for Acute Life-Threatening Conditions - United States, January-May 2020. MMWR Morb Mortal Wkly Rep. 2020; 69(25): 795–800.
- Sinha P, Matthay MA, Calfee CS. Is a "Cytokine Storm" Relevant to COVID-19? JAMA Intern Med. 2020 [Epub ahead of print].
- Toubiana J, Poirault C, Corsia A, et al. Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study. BMJ. 2020: m2094.
- Wortham JM, et al. Characteristics of Persons Who Died with COVID-19 — United States, February 12–May 18, 2020. MMWR, Early Release / Vol. 69 July. ; 10: 2020.
- Long QX, Tang XJ, Shi QL, et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nature Medicine. 2020.
- Molina LP, Chow SK, Nickel A, et al. Prolonged Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RNA in an Obstetric Patient With Antibody Seroconversion. Obstet Gynecol. 2020 [Epub ahead of print].
- Theel ES, Slev P, Wheeler S, et al. The Role of Antibody Testing for SARS-CoV-2: Is There One? J Clin Microbiol. 2020; 58(8).
- Bastos ML, Tavaziva G, Abidi SK, et al. Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis. BMJ. 2020; 370: m2516.
- Ibarrondo FJ, Fulcher JA, Goodman-Meza D, et al. Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19. N Engl J Med. 2020 [Epub ahead of print].
- http://www.aotm.gov.pl/www/wp-content/uploads/covid_19/2020.04.25_zalecenia%20covid19_v1.1.pdf.
- Mehra M, Desai S, Ruschitzka F, et al. RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. The Lancet. 2020.
- Cao B, Wang Y, Wen D, et al. A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med. 2020; 382(19): 1787–1799.
- Cavalcanti AB, Zampieri FG, Rosa RG, et al. Coalition Covid-19 Brazil I Investigators. Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19. N Engl J Med. 2020 [Epub ahead of print].
- Beigel JH, Tomashek KM, Dodd LE, et al. ACTT-1 Study Group Members. Remdesivir for the Treatment of Covid-19 - Preliminary Report. N Engl J Med. 2020 [Epub ahead of print].
- Li L, Zhang W, Hu Yu, et al. Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial. JAMA. 2020 [Epub ahead of print].
- Casadevall A, Joyner M, Pirofski LA. A Randomized Trial of Convalescent Plasma for COVID-19—Potentially Hopeful Signals. JAMA. 2020.
- Delang L, Abdelnabi R, Neyts J. Favipiravir as a potential countermeasure against neglected and emerging RNA viruses. Antiviral Res. 2018; 153: 85–94.
- Cai Q, Yang M, Liu D, et al. Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study. Engineering (Beijing). 2020 [Epub ahead of print].
- Horby P, Lim WS, Emberson JR, et al. RECOVERY Collaborative Group. Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report. N Engl J Med. 2020 [Epub ahead of print].
- Schulert G, Meschiari M, Cozzi-Lepri A, et al. Can tocilizumab calm the cytokine storm of COVID-19? Lancet Rheumatol. 2020; 2(8): e449–e451.
- Hamiel U, Kozer E, Youngster I. SARS-CoV-2 Rates in BCG-Vaccinated and Unvaccinated Young Adults. JAMA. 2020; 323(22): 2340.
- Hick JL, Biddinger PD. Novel Coronavirus and Old Lessons - Preparing the Health System for the Pandemic. N Engl J Med. 2020; 382(20): e55.
- Castelletti S. A Shift on the Front Line. N Engl J Med. 2020; 382(23): e83.
